Characteristics | Total (%) n = 47 (100) |
---|---|
Mean age in years (SD) | 61.7(9.5) |
Gender | Â |
 Female | 18 (38.3) |
 Male | 29 (61.7) |
Chemotherapy | Â |
 First-line chemotherapy | 36 (76.6) |
 Second-line chemotherapy | 11 (23.4) |
Cancer site | Â |
 Colon/rectum | 18 (38.3) |
 Pancreas | 12 (25.5) |
 Stomach/esophagus | 13 (27.6) |
 Anal | 2 (4.3) |
 Cholangiocarcinoma | 2 (4.3) |
ECOG Performance Status | Â |
 0 | 6 (12.8) |
 1 | 29 (61.7) |
 2 | 12 (25.5) |
RECIST | Â |
 Partial Remission | 16 (34) |
 Stable Disease | 22 (46.8) |
 Progressive Disease | 9 (19.2) |
PFS-Ratio | Â |
  ≥ 1 | 30 (63.8) |
  < 1 | 17 (36.2) |
 Mean participation period in weeks (SD) | 8.8 (3.5) |